CORC

在结果中检索

CORC

浏览/检索结果: 共181条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Diamine molecules double lock-link structured graphene oxide sheets for high-performance sodium ions storage 会议论文
作者:  Zhang, Yu-Shan;  Zhang, Bin-Mei;  Hu, Yu-Xia;  Li, Jun;  Lu, Chun
收藏  |  浏览/下载：16/0  |  提交时间：2020/12/18
FeMo sub-nanoclusters/single atoms for neutral ammonia electrosynthesis 会议论文
作者:  Liu, Wei;  Han, Lili;  Wang, Hsiao-Tsu;  Zhao, Xueru;  Boscoboinik, J. Anibal
收藏  |  浏览/下载：13/0  |  提交时间：2020/12/18
Optimization design of space mirror support based on topology optimization method 会议论文
Shanghai, China, 2019-03-17
作者:  Xu, Wen Jing;  Wang, Wei;  Qu, Yan Jun;  Liu, Bei;  Li, Xu Peng
收藏  |  浏览/下载：35/0  |  提交时间：2019/08/14
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Dielectric Properties and 3D Printing Fesibility of UV Curable Polymer Composites 会议论文
作者:  Li, Wen-Dong;  Zhang, Li-Yuan;  Wang, Chao;  Li, Xiao-Ran;  Xu, Man
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/19

©版权所有 ©2017 CSpace - Powered by CSpace